Novo Nordisk A-S (Class B)

7.08.2024 г., 10:13 ч. UTC

Novo Nordisk's Wegovy Sales Disappoint -- 2nd Update

7.08.2024 г., 06:58 ч. UTC

Wegovy Maker Novo Nordisk Lifts Sales Guidance as Weight-Loss Drug Demand Continues to Surge -- Update

7.08.2024 г., 06:10 ч. UTC

Wegovy Maker Novo Nordisk Lifts Sales Guidance as Weight-Loss Drug Demand Continues to Surge

3.09.2024 г., 11:09 ч. UTC

Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly. -- Barrons.com

27.08.2024 г., 05:30 ч. UTC

Weight-Loss Drugs Get More Good News. For Investors, It's Still Too Soon to Celebrate. -- Barrons.com

14.08.2024 г., 12:01 ч. UTC

Novo Nordisk's Pricing and Pipeline to Remain Hot Topics -- Market Talk

9.08.2024 г., 11:30 ч. UTC

Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race -- Heard on the Street -- WSJ

9.08.2024 г., 07:30 ч. UTC

Novo Nordisk Share Pullback Represents Great Opportunity -- Market Talk

8.08.2024 г., 15:44 ч. UTC

Eli Lilly Shows We Haven't Hit Peak Obesity Yet -- WSJ

8.08.2024 г., 11:36 ч. UTC

Novo Nordisk's Share-Price Weakness Provides an Opportunity -- Market Talk

8.08.2024 г., 07:16 ч. UTC

Novo Nordisk's Share-Price Drop Provides Buying Opportunity -- Market Talk

7.08.2024 г., 20:30 ч. UTC

Eli Lilly Reports Earnings Thursday Amid a Stock Slump. Here's What to Expect. -- Barrons.com

7.08.2024 г., 16:39 ч. UTC

Novo Nordisk's Wegovy Sales Disappoint -- Update

7.08.2024 г., 15:30 ч. UTC

Novo Nordisk's Wegovy Sales Disappoint -- WSJ

7.08.2024 г., 14:22 ч. UTC

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

7.08.2024 г., 12:28 ч. UTC

Novo Nordisk's Core Products Disappoint -- Market Talk

7.08.2024 г., 12:04 ч. UTC

Novo Nordisk Execs Were Speaking on a Call After 2Q Earnings

7.08.2024 г., 11:34 ч. UTC

Novo Nordisk US Head: As Wegovy Volumes Go Up, Prices Will Come Down

7.08.2024 г., 11:34 ч. UTC

Novo Nordisk CEO: When You Move Into New Sales Channels it Comes With a Discount

7.08.2024 г., 11:34 ч. UTC

Novo Nordisk CEO: Wegovy Now Covered in 20 States Through Medicaid

7.08.2024 г., 11:05 ч. UTC

Novo Nordisk Delivers Messy Quarter as Wegovy Misses The Mark -- Market Talk

7.08.2024 г., 10:55 ч. UTC

Stock Market Madness Highlights This Problem for -2-

7.08.2024 г., 10:55 ч. UTC

Stock Market Madness Highlights This Problem for Novo Nordisk and Super Micro. And 5 Other Things to Know Today. -- Barrons.com

7.08.2024 г., 09:07 ч. UTC

Stocks to Watch Wednesday: Super Micro, Rivian, Airbnb -- WSJ

7.08.2024 г., 08:55 ч. UTC

These Stocks Are Moving the Most Today: Super Micro, Lumen, Airbnb, Rivian, Fortinet, Upstart, Disney, and More -- Barrons.com

7.08.2024 г., 07:32 ч. UTC

Novo Nordisk Wegovy Sales Disappoint -- Market Talk

7.08.2024 г., 05:45 ч. UTC

Novo Nordisk Declares Interim Dividend of DKK3.50

7.08.2024 г., 05:44 ч. UTC

Novo Nordisk 2Q Gross Margin 84.9% Vs 85.5%, Op Margin 38.1% Vs 44.0%

7.08.2024 г., 05:40 ч. UTC

Novo Nordisk 2Q Wegovy Drug Sales DKK11.66B Vs DKK7.52B

7.08.2024 г., 05:38 ч. UTC

Novo Nordisk: Sales Growth Has Resulted in Periodic Supply Constraints, Related Drug Shortage Notifications